LIQUIDIA CORPORATION

LQDA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Aug 2025 Jun 2025 May 2025 Mar 2025 Mar 2025 Dec 2024 Oct 2024 Sep 2024
Revenue $8.8M $3.1M $2.9M $4.4M
Cost of Revenue $1.5M $1.6M
Gross Profit $1.6M $2.9M
Gross Margin 51.4% 64.8%
Operating Expenses
Research & Development $6.0M $7.0M $11.9M
SG&A Expense $38.8M $30.1M $20.2M
Operating Income $-37.5M $-35.4M $-36.1M $-29.2M
Operating Margin -424.4% -1,135.4% -1,237.8% -656.2%
Interest Expense $3.0M
Pretax Income $-41.6M $-38.4M
Income Tax Expense $0 $0
Net Income $-41.6M $-38.4M $-38.5M $-31.0M
Net Margin -470.5% -1,229.7% -1,320.2% -697.6%
EPS (Basic) $-0.49 $-0.45 $-0.45 $-0.40
EPS (Diluted) $-0.49 $-0.45 $-0.45 $-0.40
Shares Outstanding (Basic) 86.1M 85.6M 85.5M 85.2M 85.3M 84.7M 84.6M 78.3M
Shares Outstanding (Diluted) 86.1M 85.6M 85.5M 85.2M 85.3M 84.7M 84.6M 78.3M
Dividends Per Share
← Newer Page 2 of 7 Older →